ABBV Replacing GILD
You could say GILD replaced ABBV after I took its profit and now ABBV is back after I took GILD's profit. It may sound slick, but it is really just…
You could say GILD replaced ABBV after I took its profit and now ABBV is back after I took GILD's profit. It may sound slick, but it is really just…
A look at the general Healthcare ETF (XLV), which includes BioPharma, Devices/Equipment and Services shows it easing below the trend line. IHI is at lateral support and the SMA 50…
A couple of charts from the weekly Market Internals segment of NFTRH, bearing in mind that interest rates are going to have a say about sector relative strength going forward…
Since this is a spot on the internet that is not trying to harvest your eyeballs (no ads, man), misrepresent itself as a guru service or otherwise present uneven views…
It's been a great run off the June bottom and now all Biotech profits are booked. I'll hold general Healthcare for now, with all individual stocks in the books (except…
Back in April of this year we did an NFTRH+ on BioPharma ABBV and its amazingly similar setup to 2016's NFTRH+ pick, LRCX. The original target was noted as 84,…
There was the high, tight one on Biotech iShares, IBB and then others noted on the Medical Device iShares, IHI and the general sector SPDR, XLV. Well, there ya go.…
This "amateur cyclist's" chart (I am anything but a cycles analyst) of the S&P 500 shows that the 12 month marker (C12) meant exactly nothing as the market remained firmly…
The Consumer Staples SPDR is breaking down vs. SPY on the weekly line chart. The break below the channel line would magically disappear if the ratio recovers in month for…
There are some stocks that I can never seem to get a handle on and there are others that I can never seem to screw up on. Goldman Sachs is…
We noted the high, tight one on IBB yesterday and today it and its bros in the Healthcare sector appear to want to break these bull flags. In line with…
The Biotech iShares IBB shot up on some beneficial talk out of the Trump administration and, in my opinion, on beneficial Treasury yield dynamics. So it is no coincidence that…
We have used this chart in NFTRH to gauge the state of the ongoing secular bull market in Biotech vs. other Tech. The series of higher highs and higher lows…
In an NFTRH update this morning we reviewed the charts of the leader (NDX) and its leader (SOX). Here we see the Semi leadership (to NDX) that kicked in a…